C2I2.org
 Index to all volumes
  2008
  2007
  2006
  2005
  2004
  2003
 Useful web site addresses
 Contacting C2I2

Search for:
Type a word or a phrase. All forms of the word are searchable.

Click here to register to get free access to the newest editions on-line

Supported by


Professor Norbert Lameire is Emeritus Professor of Medicine at the Medical Faculty of Ghent University. He received his training in internal medicine and nephrology at the University of Ghent, Faculty of Medicine. He was appointed Professor of Medicine in 1991 and he became Chief of the Renal Division at the University Hospital and was Chairman of the Department of Medicine from 1999-2004. He is Co-Chair of Kidney Disease Improving Global Outcomes (KDIGO), a global nephrology initiative. Professor Lameire serves on the editorial boards of many medical societies and associations; he is Editor-in-Chief of Nephrology, Dialysis, Transplantation and Acta Clinica Belgica. His research interests include both basic research (renal circulation in experimental ARF and the peritoneal circulation) and clinical topics, including clinical ARF, peritoneal dialysis, and organisational and economic aspects of chronic renal replacement therapy and transplantation.
Screening of renal function prior to administration of iodinated contrast medium

Norbert Lameire
Emeritus Professor of Medicine,
University Hospital, Ghent, Belgium

Address for correspondence:
Professor Norbert Lameire
Department of Medicine, University Hospital
185 De Pintelaan, 9000
Ghent, Belgium
Tel: +32 (0)9-240-4402 Fax: +32 (0)9-240-4403
Email: norbert.lameire@ugent.be


Assessment of baseline renal function
Abstract

Renal impairment at baseline (estimated glomerular filtration rate [eGFR] <60 ml/min/1.73 m2) is the most important risk marker to predict the risk of contrastinduced nephropathy (CIN) in patients receiving iodinated contrast media. A number of strategies have been shown to be helpful in managing the risk of CIN in patients at risk of CIN. Hence, it is important to assess renal function before administration of contrast medium to ensure that appropriate steps are taken to reduce the risk. Serum creatinine alone does not provide a reliable measure of renal function, and thus the National Kidney Foundation Kidney Disease Outcome Quality Initiative (K/DOQI) recommends that clinicians should use an eGFR calculated from the serum creatinine as an index of renal function. eGFR should be determined prior to contrast administration, using the abbreviated Modification of Diet in Renal Disease (MDRD) formula, recommended by K/DOQI as the preferred equation for the calculation of eGFR in adults. Where a serum creatinine measurement or eGFR is not available, a simple survey or questionnaire can be used before contrast agent administration to identify patients at higher risk for CIN than the general population. In emergency situations, where the benefit of very early imaging outweighs the risk of waiting, the investigation or procedure can be undertaken without assessment of renal function.